Illawarra Institute for Mental Health and School of Psychology, University of Wollongong, NSW, 2522, Australia.
J Subst Abuse Treat. 2011 Jun;40(4):397-404. doi: 10.1016/j.jsat.2011.01.002. Epub 2011 Feb 25.
There has been much international impetus to address the importance of identifying and treating clients experiencing both a substance use disorder and a mental disorder in treatment settings. Gaps in the literature still exist after a decade of research into this area. There is little research on the prevalence of co-occurring mental disorders (CODs) in the residential alcohol and other drug (AOD) treatment modality. In this study, the mental disorder status of 278 participants resident in AOD treatment settings across Australia was estimated using the Addiction Severity Index-Self Report (J.S. Cacciola, A. Pecoraro, & A.I. Alterman, 2008) and the Mental Health Screening Form III (J.F.X. Carroll & J.J. McGinley, 2001). The estimated rate of diagnosable Axis I mental disorder comorbidity varied from 64% to 71% depending upon which cutoff score was used with the MHSF-III. Missing data emerged as a major limitation of the self-report version of the Addiction Severity Index psychiatric composite score in this population.
在治疗环境中识别和治疗同时患有物质使用障碍和精神障碍的患者的重要性，已经引起了国际上的广泛关注。尽管该领域已经进行了十年的研究，但文献中仍存在空白。在澳大利亚的酒精和其他药物（AOD）住院治疗模式中，同时存在精神障碍（CODs）的流行程度的研究很少。在这项研究中，使用成瘾严重程度指数自我报告版（J.S. Cacciola、A. Pecoraro 和 A.I. Alterman，2008）和心理健康筛查表 III（J.F.X. Carroll 和 J.J. McGinley，2001），对澳大利亚各地 AOD 治疗机构的 278 名住院患者的精神障碍状况进行了估计。根据 MHSF-III 使用的哪个截断分数，可诊断的轴 I 精神障碍共病的估计发生率从 64%到 71%不等。在该人群中，成瘾严重程度指数精神病学综合评分的自我报告版本中出现的缺失数据是一个主要限制。
